The President of an American biosciences company has applauded the University of Leicester for its work into ground-breaking identification of new treatment for infectious hospital bugs.
Phil Young, from AmpliPhi Biosciences Corporation, also commented on his excitement at working with Dr Martha Clokie, the lead scientist at the university.
We are very excited about this partnership with Dr Clokie and the University of Leicester. Phage-based therapy has the potential to revolutionise the way C diff infections are treated in the clinic, in compliance with the regulatory frameworks already in place. We firmly believe that this collaboration may result in a treatment that could benefit patients, clinicians and health-care organisations alike.
More top news
Police in Nottingham are growing increasingly concerned for an 18-year-old girl who has been missing for four days.
Eight people have been arrested outside a factory in Staffordshire which protesters claim is responsible for military drone supplies.
Tributes have been paid to social worker John Stollery from Nottinghamshire,who was gunned down in the Tunisia terror attack.